FDA Warns Abbott Unit Over Glucose Monitors
The U.S. Food and Drug Administration has warned an Abbott Laboratories subsidiary that quality control procedures are lacking in the manufacture of two of the company's blood glucose measuring devices....To view the full article, register now.
Already a subscriber? Click here to view full article